SUV remains the most widely used PET parameter to evaluate NHLs because it is directly associated with lymphoma aggressiveness.

Lymphocyte-activation gene 3 (LAG-3) has emerged as a key immune checkpoint regulating immune responses in the context of cancer. The inhibitory effect of LAG-3-expressing T cells contributes to ...

Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are very similar because they have the same type of ...

Lymphoid cells develop into other types of white blood cells: lymphocytes and natural killer cells. If you have leukemia, a developing stem cell in your bone marrow begins to multiply out of control.

It protects the body from infection, cancer, and other conditions. Lymph nodes are part of the immune system. They send out lymphocytes. These are a certain type of white blood cell that fights ...

Table 1 Human chemokines and chemokine receptors in lymphocyte traffic: a functional classification into inflammatory (pale green) and homeostatic (dark green) chemokines. Chemokines belonging to ...

Patients with CLL may benefit from the incorporation of more plant-based foods into their diet. 2,4 This could include adopting a flexitarian approach, in which the diet primarily consists of ...

Surgery is not often used as a treatment option for chronic lymphocytic leukemia (CLL) because the disease is usually widely spread in the bone marrow and other organs. However, surgery may sometimes ...

Patient-derived xenograft (PDX) models of chronic lymphocytic leukemia (CLL) can help analyze the biology of primary leukemic B and T cells in an in vivo setting (1–7). However, creating successful ...